The peripheral terminals of primary nociceptive neurons play an essential role in pain detection mediated by membrane receptors like TRPV1, a molecular sensor of heat and capsaicin. However, the contribution of central terminal TRPV1 in the dorsal horn to chronic pain has not been investigated directly. Combining primary sensory neuron-specific GCaMP3 imaging with a trigeminal neuropathic pain model, we detected robust neuronal hyperactivity in injured and uninjured nerves in the skin, soma in trigeminal ganglion, and central terminals in the spinal trigeminal nucleus. Extensive TRPV1 hyperactivity was observed in central terminals innervating all dorsal horn laminae. The central terminal TRPV1 sensitization was maintained by descending serotonergic (5-HT) input from the brainstem. Central blockade of TRPV1 or 5-HT/5-HT3A receptors attenuated central terminal sensitization, excitatory primary afferent inputs, and mechanical hyperalgesia in the territories of injured and uninjured nerves. Our results reveal central mechanisms facilitating central terminal sensitization underlying chronic pain.
INTRODUCTION
Small-diameter nociceptive neurons whose cell bodies reside in dorsal root ganglia (DRG) and trigeminal ganglia (TG) play essential roles in pain signal detection, transmission, and modulation (Basbaum et al., 2009) . The peripheral axons of these pseudounipolar neurons innervate tissues, such as skin, muscle, and visceral organs, to detect painful stimuli, whereas their central axons transmit these signals to secondary-order neurons in the spinal cord dorsal horn (in the case of DRG neurons) and the analogous trigeminal subnucleus caudalis (Vc, in the case of TG neurons). Peripheral tissue and nerve injury can lead to hyperalgesia, a state in which painful stimuli are perceived as more painful than normal. One major contributor to hyperalgesia is augmented sensitivity of primary nociceptive neurons, a phenomenon called peripheral sensitization (Treede et al., 1992) . Although sensitization of peripheral terminals can be readily detected by sensory nerve recordings in the skin-nerve preparation, technical barriers have limited investigation of the role of the central terminals of primary sensory neurons in sensitization and hyperalgesia.
TRPV1, a nonselective cation channel, is a key molecular component of pain detection and modulation (Caterina et al., 1997 (Caterina et al., , 2000 . Although TRPV1 protein is present throughout many nociceptive neurons (i.e., along peripheral and central axons) (Caterina et al., 2000; Guo et al., 1999) , previous studies have mainly focused on its function as a molecular sensor of noxious heat and capsaicin in the peripheral terminals. Hyperalgesia resulting from tissue injury or inflammation is often associated with sensitization of TRPV1 channel activity that can occur through several mechanisms, such as phosphorylation, interaction with phospholipid PIP 2 , trafficking, and association with accessory proteins (Bhave et al., 2002; Lukacs et al., 2007; Zhang et al., 2005 Zhang et al., , 2008 . Recent studies have implicated TRPV1 in the modulation of sensory transmission from the central terminals of primary afferents to spinal dorsal horn neurons (Gregus et al., 2012; Sikand and Premkumar, 2007; Tognetto et al., 2001; Yang et al., 1998) . However, an understanding of the mechanisms by which TRPV1 or other molecules contribute to central terminal sensitization events underlying persistent pain will require approaches that allow one to directly monitor presynaptic neuronal activity and its hyperactivity.
We combined primary sensory neuron-specific GCaMP3 imaging with a trigeminal neuropathic pain model and detected robust neuronal hypersensitivity in injured and uninjured nerves in the skin, soma in trigeminal ganglion, and central terminals in the spinal trigeminal nucleus. Strikingly, extensive TRPV1 hyperactivity was observed in central terminals innervating all dorsal horn laminae. The central terminal TRPV1 sensitization was maintained by upregulated descending serotonergic (5-HT) input from the rostral ventromedial medulla (RVM) in the brainstem. Central blockade of TRPV1 or 5-HT/5-HT3A receptor attenuated TRPV1-dependent central terminal sensitization, excitatory primary afferent inputs, and mechanical hyperalgesia in the territories of injured and uninjured nerves. Therefore, our results reveal a pain mechanism in which descending 5-HT from the RVM maintains central terminal sensitization by activation of presynaptic 5-HT3A receptors and subsequent facilitation of TRPV1 activity.
RESULTS

Generation and Initial Characterization of Pirt-GCaMP3
Mice To develop a better means of specifically monitoring primary sensory neuron activity, we generated a knockin mouse line in which GCaMP3 expression is driven by the Pirt promoter. GCaMP3 is a genetically encoded calcium indicator whose green fluorescent intensity is dramatically increased after binding to intracellular Ca 2+ and that has been used to effectively visualize neuronal activity in several animal models (Tian et al., 2009 ). The Pirt promoter is a strong and selective pan-DRG and TG promoter that is expressed in almost all primary sensory neurons (Figure S1A available online) but that is not expressed in glia, in other peripheral tissues, such as skin and muscle, or in the CNS (Kim et al., 2008) . We compared Ca 2+ imaging assays using conventional Fura2 dye loading of cultured dissociated wild-type DRG neurons and Pirt-GCaMP3 transgenic DRG neurons ( Figure S2A ). When treated with a high level of KCl (100 mM), both methods revealed activation of $87% of total DRG neurons, which is consistent with Pirt-GCaMP3 being present in almost all DRG neurons.
Developing a Mouse Trigeminal Neuropathic Pain Model
Because of its unique anatomical characteristics and clinical relevance, the trigeminal system has been used to study persistent or chronic pain. The trigeminal nerve originates from TG, which divides into three large branches: the ophthalmic (V1), maxillary (V2), and mandibular (V3), each of which innervate a distinct orofacial region ( Figure 1A ). To study peripheral and central mechanisms of neuropathic pain using Pirt-GCaMP3 mice, we adapted our rat model of chronic constriction injury of the infraorbital nerve (CCI-ION), the major branch of V2 (Klein et al., 1988) , to mice ( Figure 1A ) (Okubo et al., 2013; Wei et al., 2008) . For assessing mechanical hyperalgesia, von Frey filaments were applied to the whisker pad (injured V2 territory) or lower jaw (uninjured V3 territory) area. An active withdrawal of the head from the probing filament was defined as a nocifensive response (Movies S1 and S2). The mechanical pain threshold was quantified as EF50, the mechanical force that produced a 50% response frequency. Compared with the sham group and baseline, CCI-treated animals exhibited significant decreases in EF50s (i.e., lower mechanical pain threshold) of both ipsilateral V2 and V3 regions measured at 5, 14, and 28 days after surgery ( Figure 1B ). There was no significant change in the mechanical pain threshold of the contralateral V2 after CCI-ION ( Figure 1B) . Therefore, CCI-ION mice showed long-lasting mechanical hyperalgesia in territories innervated by injured and uninjured nerves. In addition, capsaicin-evoked nocifensive responses were also significantly increased in both ipsilateral V2 and V3 regions 14 days after CCI-ION compared to the sham group (Figures 1C and 1D) . These results indicate that the mouse CCI-ION model exhibits primary hyperalgesia in the V2 skin, which is innervated by the injured ION, as well as a spread of hyperalgesia to the V3 area innervated by the uninjured V3 nerve. (B) Mechanical hyperalgesia was tested at the ipsilateral V2 whisker pad (injured), the V3 lower jaw (uninjured), and contralateral V2 regions at 5, 14, and 28 days after CCI-ION (n = 8) or sham (n = 6) in mice. The data are expressed as an EF50 value and are presented as mean ± SEM. (C and D) Cheek injection of capsaicin evokes nocifensive facial wiping by the forepaw. The number of face wipes were measured within 30 min of capsaicin (0.5 mg) injection into the cheek (V2, injured) and the anterior part of ear skin (V3, uninjured; n = 10 for each group). Data are presented as mean ± SEM. **p < 0.01; ***p < 0.001 versus baseline (B) or sham (C and D).
Extraterritorial hyperalgesia, i.e., the hyperalgesia found within the V3 skin, is a prominent component of many clinical chronic pain conditions and is thought to be related to CNS mechanisms (Ringkamp and Meyer, 2005) .
Terminals of Uninjured Nerves in the Skin Became Hypersensitized
We next used the CCI-ION model, in combination with PirtGCaMP3 imaging, to determine whether uninjured primary afferents are involved in extraterritorial hyperalgesia. We primarily used capsaicin to probe neuronal hypersensitivity because the dosage of capsaicin application can be quantitatively controlled. The complete absence of Ca 2+ signals evoked by capsaicin in Pirt-GCaMP3;TRPV1 À/À mice confirmed that capsaicin could be used to specifically monitor TRPV1 activity ( Figure S2B ). Importantly, we also determined that CCI-ION did not change GCaMP3 protein levels in the TG of Pirt-GCaMP3 mice (Figures S1B and S1C). Because GCaMP3 was expressed in nearly all neurons in the DRG and TG of Pirt-GCaMP3 mice and its expression levels remained constant after nerve injury, Pirt-GCaMP3 mice provided a suitable tool to monitor plasticity of primary sensory neurons under neuropathic pain conditions. To examine whether neuronal activity of uninjured V3 nerves was affected by CCI-ION, we imaged peripheral nerve fiber and terminal activation in acutely isolated hairy ear skin explants from Pirt-GCaMP3 mice, 10-17 days after CCI-ION. Figure 2A shows a schematic diagram of a mouse ear and the location at which images were taken in the V3 and C2 regions of ear skin. The anterior ear skin receptive field is innervated by the V3 nerve, similar to the lower jaw, but the former is better separated from the whisker pad. The posterior part of the ear skin is innervated by the cervical C2 DRG fibers ( Figure 2A ) (Neubert et al., 2005) . To confirm the V3 innervation of the external ear, the retrograde nerve tracer DiI was injected into the skin over the anterior upper part of the external ear. DiI-labeled neurons were located in the V3, but not in the V1 or V2, division of the TG ( Figure S3A ). In contrast, DiI injection into the whisker pad (V2) only labeled neurons in V2, but not in V3, division of the TG ( Figure S3B ).
The basal GCaMP3 fluorescence level is very low in nerve fibers in the ear skin without any stimulation. Ear explants were perfused with capsaicin and washed and then treated again with a high level of KCl (100 mM). Interestingly, capsaicin application evoked robust and stronger Ca 2+ responses in multiple nerve fibers of the anterior part of ipsilateral ear skin (V3) following CCI-ION when compared to Ca 2+ responses in the contralateral ear skin (V3) and the posterior part of the ipsilateral ear skin (C2) ( Figure 2B ; Movies S3 and S4). The capsaicininduced Ca 2+ response was dose-dependent and reversible ( Figures 2B-2D ). At 1 mM capsaicin application, the peak amplitude of the absolute Ca 2+ transient (DF/F 0 ) in ipsilateral V3 (0.09 ± 0.03) was significantly greater than that of contralateral V3 (0.02 ± 0.00; n = 10 explants per group) or that of ipsilateral C2 transient (DF/F 0 ) and are presented as mean ± SEM. Black bars indicate when stimuli were applied. (F) Length of ear skin fibers and endings after activation by capsaicin (1 and 10 mM), which was normalized to the length activated by KCl. Significant increases were found in ipsilateral ear (V3) as compared to contralateral ear (V3) or ipsilateral ear (C2). *p < 0.05; **p < 0.01; ***p < 0.001. Data are presented as mean ± SEM.
(0.01 ± 0.01; n = 3, p < 0.05). We also performed area under the curve (AUC) measurements of the integrated Ca 2+ elevation evoked by applied stimuli ( Figure 2C ). AUC (1 mM capsaicin) in ipsilateral V3 (1.14 ± 0.15) was significantly larger than that of contralateral V3 (0.32 ± 0.04; n = 10 for each group; p < 0.001) or ipsilateral C2 (0.48 ± 0.08; n = 3, p < 0.05). Similar results were obtained with 10 mM capsaicin application ( Figure 2D) .
A high level of KCl activated a much larger population of afferent fibers than capsaicin did, but neither the peak amplitude nor integrated area of the KCl-evoked Ca 2+ transient differ between the three groups (ipsilateral V3, contralateral V3, and ipsilateral C2) ( Figure 2E ). This is consistent with the finding that GCaMP3 levels are the same between ipsilateral and contralateral TG after CCI-ION (Figures S1B and S1C). Besides comparing Ca 2+ signal levels, we also examined changes in the cumulative length of nerve fibers activated by capsaicin after CCI-ION. These measurements were normalized to the total length of fibers activated by high KCl and were expressed as a percentage of activated fiber length ( Figure 2F ). Following capsaicin application, the cumulative activated fiber length in ipsilateral V3 was significantly longer than that in contralateral V3 (n = 10 per group, p < 0.001) or ipsilateral C2 (n = 3, p < 0.05; Figure 2F ). Together, these data clearly indicate that hyperactivity occurs in the nerve fibers in the skin innervated by a neighboring uninjured nerve branches after CCI-ION.
Robust Hyperactivity in Multiple Cell Types in Trigeminal Ganglion after CCI-ION To evaluate neuronal activity in TG somata, we next imaged Ca 2+ response in acutely isolated TG explants from Pirt-GCaMP3 mice. An advantage of visualizing TG explants is that neuronal cell bodies in TG retain their somatotopic organization and segregation ( Figure 3A ). The percentage of neurons that responded to 1 mM capsaicin was significantly increased in CCI-ION-injured ipsilateral V2 (22.55% ± 1.84%; normalized by 100 mM KCl activation) compared with the uninjured contralateral V2 TG (12.12% ± 1.07%, p < 0.001, n = 12 explants) (Figures 3B and 3D) . However, at 10 mM capsaicin, there was no significant difference between the injured and uninjured V2 TG ( Figure 3D ; Movies S5 and S6). Similar to the V2 region, the percentage of neurons in the CCI-ION ipsilateral V3 (26.91% ± 1.05%) responding to 1 mM capsaicin was significantly increased compared to the contralateral V3 TG (14.30% ± 2.72%, n = 4, p < 0.01), but at 10 mM capsaicin, no significant difference was observed between the ipsilateral and contralateral V3 TG following CCI-ION ( Figures 3C and 3E ). Sham-operated animals did not show any difference between the ipsilalateral and contralateral V2 and V3 of TG (n = 3, p > 0.10, data not shown). Interestingly, more of the capsaicin-sensitive (1 mM) neurons in the V2 area of the ipsilateral TG (8.46% ± 2.66%, p < 0.05) had large diameter cell bodies (>30 mm) when compared to the capsaicin-sensitive neurons in the V2 of the contralateral TG (2.1% ± 0.83%, n = 12) ( Figure 3D ). In contrast, no increased activation of large diameter cell bodies was found in V3 regions from the ipsilateral compared with the contralateral TG ( Figure 3E ).
TRPV1 and Neuronal Hyperactivity in Central Terminals Innervating All Dorsal Horn Lamina
To examine the contribution of central fibers and terminals of primary sensory neurons to persistent pain, we next imaged the activation of central projecting axons and terminals of TG neurons in acute Vc slices from Pirt-GCaMP3 mice after CCI-ION. The segregation of trigeminal branches is also maintained in the central projection to Vc. V3, V2, and V1 axons terminate in the dorsomedial, middle, and ventrolateral regions of Vc, respectively (Nakajima et al., 2011; Rexed, 1952) (Figure 4A ). This unique feature of the TG system allowed us to image specific Vc subdivisions in which sensory signals are received and transmitted from injured and uninjured peripheral axons. In addition, incoming C-fibers terminate in laminae I and II, whereas A-fibers end predominately in lamina layers III and IV such that neuronal activities of different sensory fiber subtypes can be monitored accordingly (Mosconi et al., 2010) . Figure 4A shows the laminar organization of V2 and V3 in Vc and where the images were analyzed. The Vc area was sliced using conventional vibratome slicing methods. The fluorescence intensity of a subset of sensory endings in superficial laminae was increased after capsaicin treatment (Figures 4B and 4C; Movies S7 and S8) . Besides capsaicin, we also used low KCl (20 mM) to examine overall neuronal excitability. Indeed, 20 mM KCl application evoked the activation of sensory endings in the superficial dorsal horn (C-fibers) as well as in deeper laminae (A-fibers) (Figures 4B and 4C) . The GCaMP3-mediated Ca 2+ signal intensity evoked by 1 mM capsaicin was significantly increased in the ipsilateral V2 and V3 (n = 16, p < 0.01; n = 17, p < 0.01, respectively) in the Vc slice from CCI-ION mice compared with that of the contralateral side (n = 16, n = 17 slices, respectively). The significant increase of activity in the ipsilateral V2 and V3 was found in all laminae (I/IIo, IIi, III/IV; Figure 4D ). Similar results were obtained with 10 mM capsaicin ( Figure 4E ). In addition, more activated nerve terminals were seen in the ipsilateral deeper laminae (those innervated by larger diameter A-fibers) of the injured side. Low KCl showed dramatically significant increases in activity in the CCI-ION ipsilateral V2 and V3 (n = 16, p < 0.01 for both) of the Vc in all lamina ( Figure 4F ) compared with the contralateral side (n = 16 for both). Responsiveness to high KCl (100 mM) was not significantly different between the ipsilateral and contralateral V2 and V3 (n = 17, p > 0.10; n = 18, p > 0.10, respectively) ( Figure 4G ), suggesting that GCaMP3 protein levels at the central terminals were unchanged after CCI-ION. These data demonstrate the development of extensive hypersensitivity to capsaicin and low KCl in the central terminals of both injured and neighboring uninjured neurons following CCI-ION.
Descending 5-HT from RVM Is Upregulated after Nerve Injury and Essential for Neuropathic Pain The RVM in the brain stem is an important component of descending modulatory systems that project to the spinal dorsal horn and Vc and is involved in facilitatory and inhibitory modulation of nociceptive inputs (Mason, 2001; Ren and Dubner, 2002) . We and others have shown that 5-HT-dependent descending facilitation from the RVM is involved in persistent hyperalgesia after injury (Okubo et al., 2013; Suzuki et al., 2004; Wei et al., 2010) . The robust hypersensitivity in central terminals of uninjured primary sensory neurons throughout multiple laminae of the V3 division of Vc after CCI-ION suggests a possible CNS mechanism underlying the sensitization of these central terminals. Here, we investigated by immunostaining whether nerve injury causes any change in descending 5-HTpositive fibers in the Vc sections ( Figure 5A ). Indeed, 14 days after CCI-ION, there was a dramatic increase in 5-HT immunoreactivity in the ipsilateral Vc compared with the Vc from sham animals or the contralateral side ( Figure 5B ). Importantly, the descending 5-HT-positive fibers were in close vicinity to the central terminals of primary sensory neurons stained with GCaMP3 ( Figure S4A ). This is consistent with a previous study showing that descending 5-HT-positive fibers form axoaxonic contacts onto the central terminals of primary sensory neurons (LaMotte and de Lanerolle, 1983) .
Local gene transfer of a plasmid encoding a small hairpin RNA (shRNA) targeting neuronal tryptophan hydroxylase-2 (Tph-2), a key enzyme in the synthesis of 5-HT (Invernizzi, 2007) , into the RVM led to a significant reduction of 5-HT immunostaining in the Vc, confirming the specificity of the staining and the origin of the positive fibers ( Figures 5C and S4B) .
To determine the contribution of descending 5-HT to the sensitization of primary afferent central terminals in Vc after nerve injury, we imaged Vc slices obtained from CCI-ION-treated PirtGCaMP3 mice whose RVMs were treated with either Tph-2 shRNA or scrambled shRNA. Strikingly, TRPV1 hyperactivity in the central terminals in Vc was almost completely blocked by depletion of 5-HT from the RVM, but not by scrambled shRNA (Figures 5D and 5E; Figures S5A, S5B, and S5D) . This inhibitory effect of intra-RVM treatment of Tph-2 shRNA on TRPV1 hypersensitivity could be seen in laminae I to IV of both V2 (injured) and V3 (uninjured) subdivisions of the Vc. In addition, overall neuronal hyperactivity of central terminals to low KCl (20 mM) was also significantly suppressed by Tph-2 shRNA as compared to scrambled shRNA (Figures 5D and 5F; Figures S5A and S5C) . In contrast, depletion of 5-HT in the RVM had no detectable effect on central terminal responsiveness to a stronger depolarizing stimulus, high KCl (100 mM) ( Figure S5E ). Similar descending 5-HT-dependent hypersensitivity of central terminals was also observed in neighboring uninjured V1 of the Vc and C1 spinal cord slices ( Figure S6 ).
We next asked whether descending 5-HT is required for nerve injury-induced persistent pain states. We examined mechanical hyperalgesia 4 days after intra-RVM Tph-2 shRNA injection, which was also 14 days after CCI-ION. Consistent with the imaging results, mechanical hyperalgesia in the facial territories of injured (V2) and uninjured (V3) nerve fibers was significantly attenuated by the depletion of descending 5-HT from RVM neurons (p < 0.05 in V2, p < 0.01 in V3 versus before shRNA treatment) compared with the scrambled shRNA injected group (Figure 5G) . Together, these data suggest that nerve injury-induced upregulation of descending 5-HT in Vc plays an important role in sensitizing central terminals likely through TRPV1, which contributes significantly to the neuropathic pain state.
Functional 5-HT3A Receptors Are Present on Central Terminals of Primary Sensory Neurons
The 5-HT3 receptor (5-HT3AR), the only ligand-gated cation channel with excitatory function in the 5-HT receptor family, has been found to mediate descending facilitation in the development of inflammatory and neuropathic pain (Lagraize et al., 2010; Okubo et al., 2013; Suzuki et al., 2004) . 5-HT3AR is expressed in spinal and Vc dorsal horn neurons and primary afferent neurons as well as their central terminals (Doucet et al., 2007) . In order to determine whether functional 5-HT3ARs are present on primary afferent central terminals, we examined activation of 5-HT3AR on primary afferent fibers in the Vc slices from Pirt-GCaMP3 mice. Application of the 5-HT3AR agonist SR57227 (10 mM) induced increases in fluorescence signals in some terminals in Vc slices from CCI-ION Pirt-GCaMP3 mice ( Figures 6A and 6B) . Interestingly, the number of SR57227-sensitive central terminals in the Vc from CCI-ION mice was significantly higher than that found in the sham group (50% increase; n = 4; p < 0.05). The specificity of SR57227 activation was determined by pretreatment with the 5-HT3AR antagonist Y25130 (10 mM), which completely abolished the Ca 2+ signals evoked by SR57227. Furthermore, SR57227 did not activate TRPV1 expressed in HEK293 cells ( Figure S8C ). Together, these data suggest that functional 5-HT3ARs are present and upregulated in the central terminals after nerve injury.
5-HT3AR Mediates the Sensitization of Central Terminals and TRPV1
It is possible that the sensitization of central terminals we detected after nerve injury is mediated by upregulated and spontaneously released 5-HT via activation of 5-HT3ARs on central terminals. To test this possibility, we perfused 5-HT3AR antagonist Y25130 (10 mM) onto Vc slices from CCI-ION Pirt-GCaMP3 mice for 30 min and then stimulated the tissues with capsaicin or low KCl. The functional blockage of 5-HT3AR significantly attenuated capsaicin-evoked GCaMP3 signals in the ipsilateral central terminals to a level comparable to that in the contralateral side of Vc slices from CCI-treated mice (Figures 6C and 6D ; Figures S7A , S7B, and S7D). The decrease in TRPV1 hyperactivity caused by Y25130 occurred in all laminae of the dorsal horn in both V2 (injured) and V3 (neighboring uninjured) subdivisions of the Vc (Figures 6C and 6D ; Figures S7A, S7B , and S7D). In addition, overall neuronal hypersensitivity of central terminals evaluated by low KCl (20 mM) was also significantly suppressed by the 5-HT3AR antagonist pretreatment compared with the contralateral side (Figures 6C and 6E ; Figures S7A and S7C ). In contrast, pretreatment of Y25130 had no effect on response to more robust depolarization of central terminals induced by 100 mM KCl ( Figure S7E ). To determine whether blocking 5-HT3AR function can inhibit neuropathic pain, the 5-HT3AR antagonist Y25130 (130 pmol/ 0.5 ml) was microinjected in the ipsilateral Vc 14 days after CCI-ION. Indeed, mechanical hyperalgesia in facial territories innervated by injured (V2) and uninjured (V3) nerve fibers was significantly blocked by the 5-HT3AR antagonist (p < 0.01, versus before drug; Figure 6F ). These data suggest that 5-HT3AR activation in Vc may mediate medullary mechanisms of 5-HTdependent descending facilitation underlying central terminal sensitization of uninjured nerves responsible for neuropathic pain.
5-HT3AR Activation Facilitates Excitatory Presynaptic Input from Primary Afferents via TRPV1 Sensitization
In order to determine the functional changes in Vc 5-HT3AR and presynaptic TRPV1 in the regulation of Vc glutamatergic transmission in trigeminal neuropathic pain after CCI-ION, we conducted whole-cell patch-clamp recordings of Vc neuronal activity in horizontal brainstem slices from adult mice. As shown in Figures 7A-7C , spontaneous miniature excitatory postsynaptic currents (mEPSCs) were recorded from lamina II neurons identified by an evoked monosynaptic response to the attached trigeminal nerve root. Ad/C fibers were electrically stimulated ( Figure S8A ) from attached dorsal roots of Vc slices from naive mice and from the ipsilateral side of Vc slices from CCItreated mice 14 days after injury. Application of the AMPA/ kainite receptor antagonist CNQX (10 mM) completely blocked mEPSCs (n = 3 neurons), confirming that the recorded EPSCs were induced by glutamatergic transmission. The frequency of mEPSCs recorded in V3 neurons was significantly increased 14 days after CCI-ION (7.5 ± 0.44 Hz; p < 0.001), compared to that in naive mice (2.4 ± 0.43 Hz). There was also a significant increase in mEPSC amplitudes after nerve injury (40.3 ± 1.42 pA; p < 0.05) compared to naive mice (33.6 ± 1.9 pA) ( Figure 7A ), suggesting both enhanced presynaptic excitatory input from primary nociceptive afferents and enhanced postsynaptic neuronal excitability. Moreover, in 9 out of 12 recorded V3 neurons from the Vc slices of mice 14 days after CCI-ION, bath application of the selective TRPV1 antagonist AMG9810 reversibly attenuated the CCI-induced increase in mEPSCs frequency but had no effect on the mEPSCs amplitudes (p < 0.001; Figures 7B and 7D; Figure S8B ). The same dose of AMG9810 had no effect on EPSCs in V3 neurons from naive mice ( Figure 7E ). We tested AMG9810 in HEK293 cells to ensure its specificity to TRPV1, and it did not block 5-HT3AR activation ( Figure S8D ). These findings indicate that central terminal TRPV1 sensitization contributes to enhanced glutamatergic input from the uninjured trigeminal nerve after CCI-ION. In addition, application of the 5-HT antagonist Y25130 into Vc slices also significantly blocked increased frequency (p < 0.05, n = 7), but not amplitude of mEPSCs (Figures 7C and 7D ), suggesting that presynaptic 5-HT3ARs in the central terminals are involved in the facilitation of primary afferent excitatory input.
Next, we recorded spontaneous EPSCs (sEPSCs) in V3 lamina II neurons of the Vc slices from naive mice in the absence of TTX. We observed that superfusion of 5-HT3AR agonist SR57227 (n = 7) in Vc slices significantly increased the frequency, but not amplitude, of sEPSCs (p < 0.001 versus baseline), which was partially reversed by pretreatment of AMG9810 (p < 0.05 versus SR57227 alone, n = 5) ( Figure 7E ). These data suggest that presynaptic TRPV1 mediates 5-HT3AR activation-induced enhancement of primary afferent glutamatergic release in Vc.
Finally, we examined what effect blockade of central terminal TRPV1 function would have on CCI-induced pain behavioral responses. Microinjection of AMG9810 into the ipsilateral Vc significantly attenuated mechanical hyperalgesia (p < 0.05, n = 6) 14 days after CCI and had no effect on mechanical thresholds in the sham group (n = 6) ( Figure 7F ). A recent report has shown that TRPV1 is also expressed in interneurons in the spinal dorsal horn, which contributes to the development of neuropathic pain (Kim et al., 2012) . Kim et al. (2012) also demonstrated that 5 days (C) Central terminals in V3 of ipsilateral Vc slices after nerve injury were bath pretreated with either the 5-HT3AR antagonist (lower panels) or vehicle (upper panels) for 30 min and then were activated by capsaicin (1 mM) or low KCl. Scale bar, 50 mm.
(D and E) Strong hypersensitivity of central nerve fibers and terminals in Vc after nerve injury is significantly blocked by the antagonist. Time course of the amplitude of the Ca 2+ transient that was evoked by capsaicin (1 mM) or low KCl application at V3 in Vc. Ipsi., ipsilateral (n = 15); cont., contralateral (n = 14); ipsi./ ant., ipsilateral antagonist (n = 12); cont./ant., contralateral antagonist (n = 8).
(F) Mechanical hyperalgesia was tested in V2 (injured) or V3 (uninjured) region at 14 days before and 30 min after intra-Vc 5-HT3AR antagonist (n = 8) or vehicle (n = 6) injection in nerve injury or sham mice (n = 8, n = 6 for antagonist or vehicle, respectively). *p < 0.05; **p < 0.01; ***p < 0.001. Data are presented as mean ± SEM.
Neuron
Mechanism of Central Terminal TRPV1 Sensitization after an intraperitoneal (i.p.) injection of the TRPV1 agonist resiniferatoxin (RTX), TRPV1 + neurons in the DRG, but not in the spinal cord, were selectively ablated. We i.p. injected RTX into CCI-ION mice in order to distinguish the action of TRPV1 at the central terminals of primary sensory neurons and dorsal horn neurons. However, we did both GCaMP imaging and pain behavioral testing 1 day after RTX treatment, instead of 5 days after treatment as done by Kim et al. (2012) . The reason for this modification was that we wanted to use RTX to silence presynaptic TRPV1 channels, but not ablate the TRPV1 + primary sensory neurons. Ablation of TRPV1 + neurons, as seen 5 days after RTX injection, would prevent us from analyzing the hyperactivity of presynaptic TRPV1 and their contribution to mechanical hyperalgesia. Capsaicin and low KCl-evoked neuronal hyperactivity of the Vc central terminals from RTX treated animals (i.e., 14 days after CCI-ION and 1 day after RTX injection) was significantly decreased when compared to vehicle-treated CCI-ION mice ( Figures 8A-8C) . However, high KCl-induced depolarization of the central terminals from RTX and vehicle-treated Vc slices were comparable ( Figure 8D ), indicating the central terminals are still functional after RTX treatment. Strikingly, after RTX treatment (n = 7), CCI-ION mice exhibited a significant reduction in mechanical hypersensitivity compared with CCI-ION mice treated with vehicle (n = 8) ( Figure 8E ). The selective reduction of TRPV1 mRNA level in the TG was confirmed at 5 days after RTX injection by quantitative real-time PCR ( Figure 8F) . However, the expression of TRPV1 by intrinsic neurons in the Vc was not affected by the RTX treatment even after 5 days. This indicated that systemic RTX did not silence TRPV1 in the dorsal horn neurons. These data suggest that central terminal TRPV1 is essential for nerve injury-induced mechanical hypersensitivity.
DISCUSSION
Imaging neuronal activity in primary sensory neurons from tissue explants and slices has been a challenge given that their nerve endings and cell bodies are densely surrounded by other cells and therefore are difficult to selectively load with Ca 2+ -sensitive chemical dyes. By specifically expressing a genetically encoded Ca 2+ -sensitive indicator in almost all DRG and TG neurons in
Pirt-GCaMP3 mice, we successfully detected activation of primary sensory neurons in the trigeminal system at peripheral and central terminals as well as in their cell bodies, in tissue explant, and in slice preparations. The advantages of this method are manifold: simple tissue preparation and imaging procedures, excellent spatial resolution, sensitive, high-efficiency simultaneous imaging of multiple neurons, preservation (D) Normalized to the predrug treatment baseline mEPSCs, pooled data show significant reduction of frequencies (left) of mEPSCs in V3 neurons with blockade of Vc TRPV1 (n = 9) or 5-HT3AR function (n = 6) 14 days after CCI. However, there was no change of the amplitudes of mEPSCs (right). *p < 0.05, ***p < 0.001 versus before drugs. (E) Upper: typical traces showed sEPSCs (in the absence of TTX) during control, application of 5-HT3AR agonist SR57227 (10 mM, 3 min), pretreatment of AMG9810 plus application of SR57227, and application of AMG9810 alone in one V3 neuron of the Vc slices from naive mice. Bottom: normalized to the baseline sEPSCs, pooled data demonstrated that 10 mM SR57227-induced increase of the frequency (the left), but not of the amplitude (the right) of sEPSCs in seven neurons from the Vc slices of naive mice. Pretreatment of AMG9810 attenuated SR57227-induced increase of the frequency of sEPSCs without effects on baseline control. ***p < 0.001, versus baseline control; # p < 0.05 versus SR57227 alone.
(F) Effects of intra-Vc injection of AMG9810 (5 pmol/0.5 ml) on CCI-induced mechanical hyperalgesia 14 days after nerve injury (n = 6-8 mice per groups). **p < 0.01, versus baseline; #, p < 0.05 versus before drug treatment. Data are presented as mean ± SEM.
of somatotopic organization, and stable expression of GCaMP3 after nerve injury. Previous immunostaining data have shown that nerve injury causes large diameter neurons that normally do not express TRPV1 to become TRPV1 positive (Hudson et al., 2001) . Consistent with these findings, our imaging data demonstrate that following nerve injury, the somata of many large diameter neurons in the injured V2 are activated by capsaicin. Although some of these may represent C or Ad-nociceptors, others are likely to include large-diameter low-threshold Ab mechanoreceptors; this corresponds with our observation of increased capsaicin sensitivity in projections to lamina III and IV of the Vc, which normally receive only large-diameter nonnociceptive input (Devor, 2009; Li et al., 2011) . These findings support the idea of a phenotypic switch in injured neurons that formerly detected only innocuous stimuli to a state involving nociceptor-like characteristics (Costigan et al., 2009) . Although a similar gain of capsaicin sensitivity was not evident from imaging of the uninjured V3 somata, examination of the uninjured afferents innervating lamina III and IV of the Vc showed acquired capsaicin sensitivity (comparing Figures 4D and 4E with Figures 3D  and 3E ). Furthermore, responsiveness to low KCl was also augmented in the central terminals of both injured and uninjured afferents, indicating overall neuronal sensitization. These data suggest that sensitization occurs in both injured and uninjured afferents and that sensitization in the central terminals of uninjured neurons is more evident than in their cell bodies.
Recent studies from our and other groups have shown that descending 5-HT from the RVM facilitates persistent pain (Okubo et al., 2013; Wei et al., 2010) . However, the underlying mechanisms are far from clear, because many 5-HT receptor subtypes are present on both central terminals of primary sensory neurons and intrinsic dorsal horn neurons. Therefore, it is difficult to determine onto which neuronal population and nerve fibers within the dorsal horn, 5-HT exerts a facilitating effect. In fact, most studies have focused on the effect of descending modulation on intrinsic dorsal horn neurons. We identified a mechanism in which supraspinal descending 5-HT sensitizes the central terminals of primary sensory neurons via a cascade that successively involves presynaptic 5-HT3AR and TRPV1 to promote chronic neuropathic pain ( Figure 8G ). After nerve injury, the upregulation of descending 5-HT and subsequent engagement of primary afferent central terminal 5HT3AR activation are likely drivers of central sensitization in addition to postsynaptic effects on dorsal horn neurons. Our study demonstrates that central terminal sensitization driven by supraspinal descending facilitation contributes to spinal sensitization and spreading pain hypersensitivity from injured (V2) to surrounding uninjured (V3) territories during some persistent or chronic pain states.
Clinical studies have demonstrated an analgesic effect of selective 5-HT3R antagonists in patients with neuropathic pain (McCleane et al., 2003) . Our findings suggest approaches for treatments with 5-HT3R antagonists in chronic pain conditions in which active descending facilitation possibly maintains central terminal sensitization. The development of agents that suppress 5-HT/5-HT3R-dependent and TRPV1-involved central terminal sensitization may be necessary to achieve favorable treatment effects.
Previous studies have shown that TRPV1 activity can be potentiated by 5-HT via both metabotropic and ionotropic 5-HT receptors, such as 5-HT2, 3, 4, and 7 receptors (Loyd et al., 2011; Ohta et al., 2006; Sugiuar et al., 2004) . Multiple signaling pathways, including protein kinase A and C (PKA and PKC), have been implicated in the potentiation. It is conceivable that other 5-HT receptors other than 5-HT3AR are involved in the central terminal TRPV1 sensitization. A candidate molecular link between 5-HT3AR and its downstream effector TRPV1 is PKC because it can be activated by 5-HT3AR and phosphorylation of TRPV1 by PKC leads to potentiation of TRPV1 activity (Khan and Hichami, 1999; Vay et al., 2012) . Previous studies have shown that the sensitization of TRPV1 resulted in larger membrane depolarizations that led to a lower threshold of neuronal activation and increased overall excitability (Neelands et al., 2008; Zhang et al., 2011) . Low KCl, which induced weak excitation of naive central terminals in contralateral Vc, could strongly activate the central terminals in ipsilateral Vc as indicated by increase in Ca 2+ signals. The stronger activation by low KCl is due to sensitization of TRPV1 in the ipsilateral central terminals. It has also been previously reported that TRPV1 activation in cranial visceral afferent terminals allows calcium entry into the terminals; this entry increases the rate of glutamate vesicle fusion and release (Shoudai et al., 2010) . So while TRPV1 acts as a molecular sensor for noxious heat and capsaicin in peripheral nerve terminals, its hyperactivity in central terminals also contributes to overall central terminal sensitization during chronic pain states. Although TRPV1 is not a mechanotransducer per se, blocking its activity centrally inhibited mechanical hyperalgesia. Therefore, our current study directly demonstrates a role for TRPV1 and its facilitation in the central terminals and a strategy to treat chronic pain. It is possible that TRPV1-independent mechanisms also contribute to the neuronal hypersensitivity of the central terminals of primary sensory neurons because 5-HT3AR may modulate other downstream channels besides TRPV1. Our current study has been focused on a CNS mechanism of central terminal sensitization by 5-HT-dependent descending facilitation after nerve injury. Several possible mechanisms might contribute to the sensitization of uninjured peripheral terminals in the skin. It appears unlikely that sensitization of terminals in the V3 ear skin is due to a direct interaction between the terminals of injured nerves in the V2 skin and those of uninjured nerves in the V3 ear skin, because the distance between the two receptive fields examined is large. Given that the most distal site of close contact between the V2 and V3 neurons is within the trigeminal ganglion, a more likely mechanism is that the somata of injured nerves, their central axons, and/or the intraganglionic domains of their peripheral axons secrete molecules, such as nerve growth factor, to sensitize neighboring uninjured nerves . By retrograde and anterograde trafficking of channels, receptors, and other molecules, nerve endings in the skin and in the spinal cord/Vc, respectively, would then become hypersensitive to painful stimuli. Future experiments combining GCaMP imaging with pharmacological, electrophysiological, and genetic approaches will be necessary to definitively address these mechanistic possibilities. Regardless, our current study directly demonstrates a role for TRPV1 and its facilitation in primary afferent central terminals and a strategy to treat chronic pain. 
Animal Model
All experiments were performed in accordance with the protocols approved by the Animal Care and Use Committee at the Johns Hopkins University School of Medicine and University of Maryland Dental School. The mice used in the tests were backcrossed to C57Bl/6 mice for at least six generations and were 1-to 2-month-old males. To produce the CCI-ION model, chronic constriction injury was performed using loose ligatures of unilateral ION via an intraoral approach. Mice were anesthetized with pentobarbital sodium (50 mg/kg i.p.), and the ION was loosely tied with two-four chromic gut (4.0) ligatures through an incision in the palatal-buccal mucosa. The incision was closed using tissue glue. The sham-operated mice received only a unilateral nerve exposure without ligatures.
Behavioral Test
Behavioral tests were conducted by experimenters blind to conditions. To reduce any effects of restraint, either by hand (Seino et al., 2009) or grasping the tail (Krzyzanowska et al., 2011) , on behavioral assessment of the mice, we adopted a less stressful method (Aita et al., 2010) and developed a more precise probing technique to test mechanical hypersensitivity in V2 and V3 skin. Mice were placed in a box (3 3 3 3 4 in) with the top, bottom, and four walls made of black wire mesh and were allowed to freely move. Von Frey filaments were applied to the skin near the center of the vibrissa pad within the infraorbital territory (V2) and the skin within the mandibular nerve territory (V3). A brisk or active withdrawal of the head from the probing filament was defined as a response. See the Supplemental Experimental Procedures for details.
Brainstem Microinjection and Gene Transfer
As previously described , Suresilencing shRNA plasmids for Tph-2 (TCAACATGCTCCATATTGAAT) and scrambled control (ggaatctcattcg atgcatac) (0.5 mg/0.5 ml) was injected into the RVM. Details are available in the Supplemental Experimental Procedures.
RTX Treatment
Eleven days after ION-CCI, mice were intraperitoneally injected with RTX or vehicle (dissolved in a mixture of 10% Tween 80 and 10% ethanol in normal saline) as a single dose in two injections of 50 mg/kg and 150 mg/kg on days 1 and 2, consecutively. The mice were injected under 3% isoflurane inhalation anesthesia and maintained anesthesia for 2-3 hr after RTX or vehicle. Mechanical thresholds and GCaMP3 imaging were performed 1 day after the second RTX injection. The mRNA levels of TRPV1 in the TG and Vc from CCI-ION mice at 5 days after RTX or vehicle injection were determined by quantitative RT-PCR using TRPV1 specific primers: 5 0 ATCATCAACGAGGACCCAGG 3 0 and 5 0 TGCTATGCCTATCTCGAGTGC 3 0 .
Pirt-GCaMP3 Ca 2+ Imaging
Ten to seventeen days after CCI-ION, 2-month-old mice were sacrificed by CO 2 asphyxiation. Ear skin, TG explants, and Vc slice was acutely isolated from Pirt-GCaMP3 mice and used to image and determine Ca 2+ transients.
All experiments were performed at room temperature ($25 C), in a chamber with stimuli applied by bath application. GFP signals from Pirt-GCaMP3 mice were measured to see Ca 2+ transients using green emitted light. Single photon Ca 2+ imaging was performed with a 700 Zeiss confocal microscope, using the 488 nm line of a solid state laser for excitation of Pirt-GCaMP3 and a 488 nm laser main dichroic beam splitter (MBS) and a 505-555 nm variable secondary dichroic mirror (VSD) to detect the emission of green fluorescence. Details are available in the Supplemental Experimental Procedures.
Whole-Cell Patch-Clamp Recording in Vc Slices The brain stem was dissected and horizontally sliced at a thickness of 400 mm. Slices were kept in an 50 ml glass beaker containing carbogenated protective aCSF at 33 C. After at least a 1 hr recovery, the brainstem slice was transferred into a recording chamber and was continuously perfused (10-15 ml/min) with oxygenated Krebs' solution (composition in mM: NaCl 126, NaHCO3 26, glucose 10, KCl 2.5, CaCl2 2, MgCl2 1.2, and NaH2PO4 1.25) at room temperature. sEPSCs or mEPSCs were recorded continuously at a holding potential of À70 mV in the absence or presence of 0.5 mM tetrodotoxin, respectively. To block inhibitory transmission, 1 mM strychnine sulfate and 10 mM bicuculline methiodide were included in the superfusate in all the experiments. Blind whole-cell voltage-clamp recordings were performed with series resistance compensation using an EPC 10 amplifier. See the Supplemental Experimental Procedures for details.
Analysis
Group data are expressed as mean ± SEM. Unless otherwise noted, unpaired Student's t test was used to determine significance in statistical comparisons, and differences were considered significant at p < 0.05. Animal behavior data were analyzed with two-way ANOVA test. Patch-clamp recording data were analyzed with Mini Analysis (v. 6.0.3) (Synaptosoft). The statistical significance was set at p < 0.05 using Student's t test or Kolmogorov-Smirnov (K-S) test. cont., contralateral. (E) Effects of i.p. injection of RTX on CCI-induced mechanical hyperalgesia 14 days after nerve injury.
SUPPLEMENTAL INFORMATION
(F) Quantitative real-time PCR was performed on total RNAs isolated from TG and Vc from RTX or vehicle-injected CCI-ION mice using TRPV1-specific primers (n = 4 per group). TRPV1 levels were normalized by b-actin in each sample. *p < 0.05; **p < 0.01; ***p < 0.001. (G) Schematic illustration of the proposed mechanism. CCI-ION-induced hyperactivity of primary nociceptive fibers in TG V2 subdivision neurons and nociceptive signal input leads to dorsal horn V2 neuron activation in the Vc; neuronal activation then ascends to the thalamus and the cerebral cortex. Pain modulatory signals then descend to the RVM. Enhanced 5-HT release from the RVM leads to enhanced activation of 5-HT3ARs and subsequent TRPV1 on the central terminals of primary afferents in the V2 and V3 subdivision of the ipsilateral Vc, resulting in central terminal sensitization of injury and uninjured nerve fibers and a spread of behavioral hypersensitivity to uninjured nearby facial skin. Data are presented as mean ± SEM.
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